Your browser doesn't support javascript.
loading
Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis.
Xie, Jiangbo; Zhang, Tingting; Li, Peichun; Wang, Dong; Liu, Tao; Xu, Shunliang.
Afiliación
  • Xie J; Department of Neurology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
  • Zhang T; Department of Neurology, Weifang Traditional Chinese Hospital, Weifang, People's Republic of China.
  • Li P; Department of Rehabilitation Medicine, Weifang Traditional Chinese Hospital, Weifang, People's Republic of China.
  • Wang D; Department of Rehabilitation Medicine, Weifang Traditional Chinese Hospital, Weifang, People's Republic of China.
  • Liu T; Department of Neurology, Weifang Traditional Chinese Hospital, Weifang, People's Republic of China.
  • Xu S; Department of Neurology, Weifang Traditional Chinese Hospital, Weifang, People's Republic of China.
Drug Des Devel Ther ; 16: 3071-3085, 2022.
Article en En | MEDLINE | ID: mdl-36118165
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Daño por Reperfusión / Ferroptosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Daño por Reperfusión / Ferroptosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article